Covid-19: Novartis Launches RCT of Hydroxychloroquine
The three-arm, placebo-controlled, phase III trial will take place at more than a dozen U.S. sites...
Read More
BreakingMed
Covid-19: Hand Sanitizer Poisonings Spike
Since early March, calls to poison centers about exposures to cleaning and disinfectant chemicals...
Read More
Treatment Naive Psoriasis Patients Have Significant QoL Impairment
PROSE study finds treatment of disease not optimal Patients with moderate-to-severe psoriasis who...
Read More
Covid-19: Did It Come from Bats, a Lab Accident, a Bioweapons Experiment?
Let’s look at the evidence. Was the emergence of the novel coronavirus SARS-CoV-2 a natural event,...
Read More
Acalabrutinib Effective as First-Line Therapy for CLL
Significantly improves PFS compared to chemoimmunotherapy The Bruton tyrosine-kinase (BTK)...
Read More
Covid-19: Be Ready for The Coming Mental Health Pandemic
But pandemic’s silver lining may be more people coming together to help each other The...
Read More
Covid-19: FDA Issues Emergency Use Authorization to Sterilize N95 Masks
Authorization could allow for decontamination of 4 million respirators per day WASHINGTON —...
Read More
AI Helps Clinicians with Funduscopic Exams
Deep learning system allows for accurate screening for papilledema Papilledema, normal disks, and...
Read MorePreemptive Therapy Promising for Cutting CMV After Liver Transplant
Trial tested approach against antiviral prophylaxis in CMV-seronegative recipients Using preemptive therapy led to a lower incidence of cytomegalovirus (CMV) disease over 12 months in CMV-seronegative liver transplant recipients...
Read More
SGO: ProMisE-ing Algorithm Predicts Endometrial Cancer Progression
Algorithm helps identify which patients can be offered fertility-sparing treatment options Using...
Read More
Pregnant Women at Highest ICH Risk in Third Trimester
Study shows need for identification of high-risk pregnancies and proactive management The risk of...
Read MoreHIV Patients Face ’Staggering’ Costs for Antiretroviral, PrEP TX
Analysis of Medicare Part D coverage, finds affordable access out of sight for some People who are not eligible for low-income subsidies could pay up to a whopping $4,000 out of pocket for HIV medications each year, new...
Read More
Hypofractionated RT for Early Breast Cancer Improves Care
But no cost saving benefits A utilization management policy promoting hypofractionated...
Read More
Negative Pressure Wound Therapy Effective for Post-Surgical Healing
Results in shorter times to wound closure and higher closure rates Negative pressure wound therapy...
Read More
Exclusive Breastfeeding Reduces Postpartum MS Relapse
Effect seen through six months, but not after Exclusive breast feeding in the first 2 months...
Read More
Novel Agent Promising in Schizophrenia
Non-D2-receptor-binding agent resulted in reductions in psychosis, negative symptoms ...
Read More
Covid-19: SARS-CoV-2, We’re Just Getting to Know You
We know a lot about what we don’t know Five months in, and the shape of the Covid-19...
Read More
Mitomycin Gel Gets FDA Nod for Low-Grade Upper Tract Urothelial Tumors
The first non-surgical treatment option for a rare cancer subtype WASHINGTON — Mitomycin gel...
Read More
Covid-19: Trump Sharply Criticized for Move to Halt WHO Funding
AMA says cutting funding during a pandemic ’is not in the U.S. interests’ President...
Read More
More Screen Time, Less Parental Playtime Increase Toddler’s ASD-Like Symptoms
No increased risk of ASD diagnosis seen, however More screen time and less play with parents at...
Read More